MX2023001002A - Farmacos antivirales, composiciones farmaceuticas, y metodos. - Google Patents

Farmacos antivirales, composiciones farmaceuticas, y metodos.

Info

Publication number
MX2023001002A
MX2023001002A MX2023001002A MX2023001002A MX2023001002A MX 2023001002 A MX2023001002 A MX 2023001002A MX 2023001002 A MX2023001002 A MX 2023001002A MX 2023001002 A MX2023001002 A MX 2023001002A MX 2023001002 A MX2023001002 A MX 2023001002A
Authority
MX
Mexico
Prior art keywords
methods
pharmaceutical formulations
compounds
antiviral prodrugs
prodrugs
Prior art date
Application number
MX2023001002A
Other languages
English (en)
Inventor
Nadejda Valiaeva
Robert T Schooley
Karl Y Hostetler
James Beadle
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2023001002A publication Critical patent/MX2023001002A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente se refiere a compuestos, que incluyen profármacos antivirales, y formulaciones farmacéuticas que incluyen los compuestos, que pueden estar biodisponibles por vía oral o formularse para inyección intramuscular. Métodos para producir compuestos, tales como profármacos antivirales. Métodos para tratar la infección por coronavirus y otros virus de ARN en mamíferos. Métodos para producir un fármaco de trifosfato.
MX2023001002A 2020-07-24 2021-07-24 Farmacos antivirales, composiciones farmaceuticas, y metodos. MX2023001002A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202063055944P 2020-07-24 2020-07-24
US202063070695P 2020-08-26 2020-08-26
US202063078427P 2020-09-15 2020-09-15
US202063110596P 2020-11-06 2020-11-06
US202163145698P 2021-02-04 2021-02-04
PCT/US2021/043094 WO2022020793A1 (en) 2020-07-24 2021-07-24 Antiviral prodrugs, pharmaceutical formulations, and methods

Publications (1)

Publication Number Publication Date
MX2023001002A true MX2023001002A (es) 2023-03-01

Family

ID=79728410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023001002A MX2023001002A (es) 2020-07-24 2021-07-24 Farmacos antivirales, composiciones farmaceuticas, y metodos.

Country Status (9)

Country Link
US (1) US20230287029A1 (es)
EP (1) EP4185300A4 (es)
JP (1) JP2023535065A (es)
CN (1) CN116264827A (es)
AU (1) AU2021312946A1 (es)
BR (1) BR112023001129A2 (es)
CA (1) CA3186881A1 (es)
MX (1) MX2023001002A (es)
WO (1) WO2022020793A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20230100A (es) 2020-08-24 2023-04-28 Gilead Sciences Inc Compuestos fosfolípidos y usos de los mismos
TW202344257A (zh) 2020-10-16 2023-11-16 美商基利科學股份有限公司 磷脂化合物及其用途
JP2024532166A (ja) * 2021-08-18 2024-09-05 ギリアード サイエンシーズ， インコーポレイテッド リン脂質化合物並びにその製造方法及び使用方法
CN116554249A (zh) * 2022-01-28 2023-08-08 北京恩泰伟医药科技有限公司 抗病毒化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558466A4 (en) * 2010-04-14 2013-11-13 Univ California PHOSPHONATES HAVING REDUCED TOXICITY FOR THE TREATMENT OF VIRAL INFECTIONS
EP3401320B1 (en) * 2013-03-15 2020-05-13 The Regents of the University of California Acyclic nucleoside phosphonate diesters for use in treating human papilloma virus, cervical intraepithelial neoplasia, anal intraepithelial neoplasia, or vulvar intraepithelial neoplasia
TWI687432B (zh) * 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
US10874683B2 (en) * 2016-03-10 2020-12-29 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR102696517B1 (ko) * 2017-09-18 2024-08-21 얀센 바이오파마, 인크. 치환된 뉴클레오시드, 뉴클레오티드 및 이들의 유사체

Also Published As

Publication number Publication date
WO2022020793A1 (en) 2022-01-27
JP2023535065A (ja) 2023-08-15
CA3186881A1 (en) 2022-01-27
EP4185300A4 (en) 2024-09-25
EP4185300A1 (en) 2023-05-31
AU2021312946A1 (en) 2023-03-09
US20230287029A1 (en) 2023-09-14
BR112023001129A2 (pt) 2023-02-14
CN116264827A (zh) 2023-06-16

Similar Documents

Publication Publication Date Title
MX2023001002A (es) Farmacos antivirales, composiciones farmaceuticas, y metodos.
ZA202307575B (en) Methods and modified nucleosides for treating coronavirus infections
MX2022002897A (es) Profarmacos antivirales y formulaciones de los mismos.
PH12018550148A1 (en) Hepatitis b antiviral agents
AU2018256602A1 (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
CL2021002747A1 (es) Agentes antivirales para la hepatitis b (solicitud divisional no. 487-2020)
UY28084A1 (es) Derivados antivirales de nucleosidos
BR112018009009A8 (pt) terapia combinada de um inibidor de formação de capsídeo hbv e um interferon
MX2022016405A (es) Análogos de nucleósido de 1¿-ciano y usos de estos.
WO2004074270A3 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
ECSP13010937A (es) Compuestos antivirales
CA2753382C (en) Hepatitis c virus inhibitors
CR8935A (es) Inhibidores de la arn polimerasa dependiente del arn del virus de la hepatitis c y composiciones
CL2008003431A1 (es) Compuestos derivados de nucleosidos 2',4' sustituidos; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; su metodo de preparacion; y su uso para el tratamiento y/o la prevencion de cualquier condicion resultante de una infeccion por vhb, vhc o vih.
WO2010081082A3 (en) Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
MY197236A (en) 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
GB2503066A8 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
BR112017000320A2 (pt) métodos para o tratamento de infecções virais de hepatite b e hepatite d
CR20230100A (es) Compuestos fosfolípidos y usos de los mismos
BR112018015629A2 (pt) ?composto, composição, método para tratar um mamífero infectado com o vírus hiv, e, proteína mutante tripla?
CR20220508A (es) Composición farmacéutica para la prevención o tratamiento de enfermedad infecciosa viral de arn epidémica
MX2023008004A (es) Derivado de adenosina y composicion farmaceutica que lo comprende.
WO2009129798A3 (de) Di- und triphosphat-prodrugs, insbesondere nukleosiddi- und -triphosphat-prodrugs
AU2020353055A8 (en) Antiviral pyrazolopyridinone compounds
WO2023146974A3 (en) Antiviral prodrugs, intermediate- and long-acting formulations and methods